Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease
about
Implication of inflammatory signaling pathways in obesity-induced insulin resistanceMAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.[Implication of MAP kinases in obesity-induced inflammation and insulin resistance].
P2860
Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tumor progression locus 2 (Tpl ...... sity-induced metabolic disease
@ast
Tumor progression locus 2 (Tpl ...... sity-induced metabolic disease
@en
type
label
Tumor progression locus 2 (Tpl ...... sity-induced metabolic disease
@ast
Tumor progression locus 2 (Tpl ...... sity-induced metabolic disease
@en
prefLabel
Tumor progression locus 2 (Tpl ...... sity-induced metabolic disease
@ast
Tumor progression locus 2 (Tpl ...... sity-induced metabolic disease
@en
P2093
P2860
P1433
P1476
Tumor progression locus 2 (Tpl ...... sity-induced metabolic disease
@en
P2093
Ashish Banerjee
Emma Estevez
George Grigoriadis
Graeme I Lancaster
Mark A Febbraio
Steve Gerondakis
P2860
P304
P356
10.1371/JOURNAL.PONE.0039100
P407
P577
2012-06-11T00:00:00Z